IP Library Assignment 061972/0730
Patent Assignment
Reel/Frame 061972/0730

Change of Name

Recorded: 2022-11-21 Pages: 13
Assignor
Assignee
SUMITOMO PHARMA CO., LTD.
6-8, DOSHOMACHI 2-CHOME, CHUO-KU, OSAKA-SHI, 541-0045 OSAKA, JAPAN
Covered Properties (70)
Oral Preparations with Favorable Disintegration Characteristics
Patent: 7,727,553 →
Application: 10/381,036 →
Publication: US 2004/0028741
Genes with Es Cell-Specific Expression
Patent: 7,250,255 →
Application: 10/479,334 →
Publication: US 2004/0137460
Quinazolinone Derivative
Patent: 7,329,665 →
Application: 10/485,865 →
Publication: US 2005/0032819
Remedy for Integration Dysfunction Syndrome
Patent: 9,174,975 →
Application: 10/525,021 →
Publication: US 2006/0025422
Process for Producing Imide Compound
Patent: 7,605,260 →
Application: 10/565,105 →
Publication: US 2006/0194970
One-Pot Process for the Preparation of 1,2-Benzisoxazole-3-Methanesulfonamide
Patent: 7,262,304 →
Application: 11/447,099 →
Publication: US 2006/0229454
Method for Sulfonation of 1,2-Benzisoxazole-3-Acetic Acid
Patent: 7,268,234 →
Application: 11/531,364 →
Publication: US 2007/0066830
Emulsified Composition for Dilution and Cancer Vaccine Composition
Patent: 8,178,102 →
Application: 11/814,270 →
Publication: US 2009/0136572
Stable Tablet Containing Droxidopa
Patent: 8,980,316 →
Application: 11/914,693 →
Publication: US 2009/0074861
Pharmaceutical Composition
Patent: 8,729,085 →
Application: 11/919,678 →
Publication: US 2009/0143404
Therapeutic Agent for Senile Dementia
Patent: 8,148,379 →
Application: 12/140,927 →
Publication: US 2008/0255148
Method of Treating Memory/Learning Dysfunctions Caused by Schizophrenia with Lurasidone
Patent: 8,835,438 →
Application: 12/401,958 →
Publication: US 2009/0176800
Amide Derivative and Pharmaceutical Composition Containing the Same
Patent: 7,906,510 →
Application: 12/734,224 →
Publication: US 2010/0249399
Tablet Quickly Disintegrating in the Oral Cavity and Method for Producing the Same
Patent: 9,119,820 →
Application: 12/997,779 →
Publication: US 2011/0105615
Process of a Quaternary Ammonium Salt
Patent: 8,921,551 →
Application: 13/093,927 →
Publication: US 2011/0263847
Process of a Quaternary Ammonium Salt Using Phosphate
Patent: 8,586,737 →
Application: 13/093,985 →
Publication: US 2011/0263848
Method of Treatment for Mental Disorders
Patent: 8,258,139 →
Application: 13/113,703 →
Publication: US 2012/0115879
Molecular Marker for Cancer Stem Cell
Patent: 8,541,544 →
Application: 13/126,039 →
Publication: US 2011/0262358
Novel Bicyclic Heterocyclic Compound
Patent: 8,471,038 →
Application: 13/141,301 →
Publication: US 2011/0294804
Process for Producing Threo-3-(3,4-Dihydroxyphenyl)-L-Serine
Patent: 8,598,370 →
Application: 13/380,205 →
Publication: US 2012/0095256
Therapeutic Agent for Senile Dementia
Patent: 8,552,000 →
Application: 13/409,075 →
Publication: US 2012/0165341
8-Azabicyclo[3.2.1]Octane-8-Carboxamide Derivative
Patent: 8,933,229 →
Application: 13/508,905 →
Publication: US 2012/0225876
Method of Treatment for Mental Disorders
Patent: 9,259,423 →
Application: 13/555,044 →
Publication: US 2013/0018056
Pyrazole Compound
Patent: 8,569,353 →
Application: 13/810,030 →
Publication: US 2013/0116296
Medicament for Treating Mental and Behavioural Disorders
Application: 13/827,655 →
Publication: US 2013/0289277
Molecular Marker for Cancer Stem Cell
Patent: 9,399,760 →
Application: 13/967,410 →
Publication: US 2014/0044686
Purine Derivatives
Patent: 8,895,570 →
Application: 13/994,321 →
Publication: US 2013/0338174
Diagnostic Drug and Diagnostic Method for Alzheimer's Disease
Application: 13/997,854 →
Publication: US 2013/0280732
Pyrazole Compound
Patent: 8,809,383 →
Application: 14/041,246 →
Publication: US 2014/0031406
Novel 1-Substituted Indazole Derivative
Patent: 9,309,221 →
Application: 14/128,516 →
Publication: US 2015/0031681
Process for Producing Imide Compound
Patent: 45,573 →
Application: 14/137,464 →
Novel 1-Substituted Indazole Derivative
Patent: 8,765,786 →
Application: 14/137,895 →
Publication: US 2014/0121243
Novel 1-Substituted Indazole Derivative
Patent: 9,051,295 →
Application: 14/137,904 →
Publication: US 2014/0121244
Pharmaceutical Composition
Patent: 8,883,794 →
Application: 14/183,283 →
Publication: US 2014/0235651
Pyrazole Compound
Patent: 9,663,472 →
Application: 14/324,509 →
Publication: US 2014/0315971
Carboxylic Acid Compounds
Patent: 9,376,398 →
Application: 14/401,366 →
Publication: US 2015/0099770
Agent for Treatment of Schizophrenia
Patent: 9,815,827 →
Application: 14/471,919 →
Publication: US 2014/0371236
Pharmaceutical Composition
Patent: 9,555,027 →
Application: 14/512,189 →
Publication: US 2015/0056284
Process of a Quaternary Ammonium Salt
Patent: 9,309,255 →
Application: 14/536,118 →
Publication: US 2015/0087830
Pharmaceutical Composition
Patent: 9,907,794 →
Application: 14/733,204 →
Publication: US 2015/0265611
Transplantation Adjuvant in Cell Therapy Using Neural Progenitor Cells
Patent: 9,884,045 →
Application: 14/891,601 →
Publication: US 2016/0106719
Cyclic Aminomethyl Pyrimidine Derivative
Patent: 9,732,065 →
Application: 14/894,402 →
Publication: US 2016/0122319
Method of Treatment for Mental Disorders
Patent: 9,827,242 →
Application: 14/994,939 →
Publication: US 2016/0193205
Method of Treatment for Mental Disorders
Application: 14/995,044 →
Publication: US 2016/0129000
Carboxylic Acid Compounds
Application: 15/152,497 →
Publication: US 2016/0251319
Molecular Marker for Cancer Stem Cell
Application: 15/162,833 →
Publication: US 2016/0367628
Novel Benzimidazole Compound and Medical Use Thereof
Application: 15/323,185 →
Publication: US 2018/0170881
Benzimidazole Compounds and Medical Uses Thereof
Patent: 9,688,670 →
Application: 15/395,338 →
Publication: US 2017/0107211
1,4-Disubstituted Imidazole Derivative
Patent: 9,828,362 →
Application: 15/443,892 →
Publication: US 2017/0166552
Pyrazole Compound
Application: 15/491,130 →
Publication: US 2017/0217902
1,4-Disubstituted Imidazole Derivative
Application: 15/507,188 →
Publication: US 2018/0230085
Pharmaceutical Composition for Injection
Application: 15/514,258 →
Publication: US 2018/0344831
Adenine Conjugate Compounds and Their Use as Vaccine Adjuvants
Application: 15/763,982 →
Publication: US 2018/0282334
Pyrimidine Compounds and Their Use as Vaccine Adjuvants
Application: 15/766,560 →
Publication: US 2018/0280499
Region Detecting Method and Region Detecting Device Related to Cell Aggregation
Application: 15/778,016 →
Publication: US 2018/0349672
Pyrazole Compound
Application: 15/990,026 →
Publication: US 2018/0273489
Medicament for Treating Mental and Behavioural Disorders
Application: 16/043,219 →
Publication: US 2018/0344730
Biheterocyclic Compound
Application: 16/070,014 →
Publication: US 2019/0016711
Imidazolylamide Derivative
Application: 16/079,952 →
Publication: US 2019/0060282
Substituted Purine Derivative
Application: 16/095,822 →
Publication: US 2019/0169191
Pyrazole Compound
Application: 16/193,232 →
Publication: US 2019/0084938
Biheterocyclic Compound
Application: 16/392,732 →
Publication: US 2019/0308958
2,6-Disubstituted Pyridine Derivative
Application: 16/487,936 →
Publication: US 2020/0039952
Deuterated Benzimidazole Compound and Medical Use Thereof
Application: 16/494,128 →
Publication: US 2020/0017450
Optically Active Azabicyclo Ring Derivative
Application: 16/748,191 →
Publication: US 2020/0157114
Condensed Lactam Derivative
Application: 16/786,053 →
Publication: US 2020/0172543
Dihydrochromene Derivatives
Application: 16/808,246 →
Publication: US 2020/0216461
2,6-Disubstituted Pyridine Derivative
Application: 16/827,981 →
Publication: US 2020/0239432
SUBSTITUTED PYRAZOLO[1,5-a]PYRAZINES AS NEGATIVE ALLOSTERIC MODULATORS OF GROUP II METABOTROPIC GLUTAMATE RECEPTOR
Application: 16/996,314 →
Publication: US 2021/0030754
Oxo-Substituted Compound
Application: 17/136,806 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 21, 2003
From: FUJIHARA, KAZUYUKI
To: SUMITOMO PHARMACEUTICALS COMPANY
Reel/Frame 014300/0005 →
Assignment of Assignor's Interest Jan 16, 2004
From: YAMANAKA, SHINYA; KAIHO, EIKO
To: YAMANAKA, SHINYA; SUMITOMO PHARMACEUTICALS CO., LTD.
Reel/Frame 015006/0299 →
Assignment of Assignor's Interest Sep 27, 2004
From: MURAOKA, MASAMI; MATSUI, KAZUKI; YAMAMOTO, TAKAAKI; MORISHITA, KOJI
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 015879/0201 →
Assignment of Assignor's Interest Feb 18, 2005
From: NAKAMURA, MITSUTAKA; OGASA, MASAAKI; SAMI, SHUNSUKE
To: SUMITOMO PHARMACEUTICALS COMPANY LIMITED
Reel/Frame 016898/0569 →
Merger/Name Change Nov 11, 2005
From: SUMITOMO PHARMACEUTICALS CO., LTD.
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 016770/0431 →
Merger Dec 16, 2005
From: SUMITOMO PHARMACEUTICALS COMPANY, LTD.
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 017089/0420 →
Merger Dec 20, 2005
From: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 017366/0816 →
Assignment of Assignor's Interest Jan 19, 2006
From: KAKIYA, YUZO; ODA, MAYUMI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 017473/0130 →
Assignment of Assignor's Interest Oct 23, 2006
From: ISHIKURA, TSUTOMU; HORIUCHI, NOBUHIKO
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 018427/0984 →
Assignment of Assignor's Interest Sep 20, 2007
From: SAITO, KOICHI; OKAWA, YUSUKE
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 019856/0298 →
Corrective Assignment to Correct the Assignee Information; to Identify Second Assignee, Which Was Inadvertently Omitted in the Previous Submission, Previously Recorded on Reel 019856 Frame 0298. Sep 25, 2007
From: SAITO, KOICHI; OKAWA, YUSUKE
To: DAINIPPON SUMITOMO PHARMA CO., LTD.; NOF CORPORATION
Reel/Frame 019879/0125 →
Assignment of Assignor's Interest Oct 31, 2007
From: FUJIHARA, KAZUYUKI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 020124/0821 →
Assignment of Assignor's Interest Nov 16, 2007
From: OCHIAI, YASUSHI; ARIYAMA, TERUKO; KOBAYASHI, HIROHISA
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 020128/0467 →
Corrective Assignment to Correct the Address of an Assignee Previously Recorded on Reel 020124 Frame 0821. Assignor(S) Hereby Confirms the Address of Assignee Is as Follows: 6-8, Dosho-Machi 2-Chome, Chuo-Ku Osaka-Shi, Osaka. May 28, 2008
From: FUJIHARA, KAZUYUKI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 021008/0209 →
Assignment of Assignor's Interest Apr 19, 2010
From: KATO, SHIRO; HARADA, HIROSHI; YAMAZAKI, HIROSHI; KAN, YOKO
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 024276/0600 →
Assignment of Assignor's Interest Dec 13, 2010
From: FUKUSHIMA, TORU; SHIMIZU, TAKASHI; YOSHIDA, TERUKO
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 025496/0628 →
Assignment of Assignor's Interest Apr 26, 2011
From: AE, NOBUYUKI; FUJIWARA, YUJI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 026180/0425 →
Assignment of Assignor's Interest Apr 26, 2011
From: AE, NOBUYUKI; FUJIWARA, YUJI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 026180/0006 →
Assignment of Assignor's Interest May 19, 2011
From: FCI
To: FCI AUTOMOTIVE HOLDING
Reel/Frame 026307/0310 →
Assignment of Assignor's Interest May 25, 2011
From: ISHIYAMA, TAKEO; IKEDA, KAZUHITO
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 026338/0591 →
Change of Name Aug 14, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033544/0234 →
Change of Name Aug 25, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033606/0307 →
Change of Name Oct 2, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033887/0248 →
Change of Name Oct 7, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033905/0778 →
Change of Name Oct 17, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 034014/0418 →